Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Dexamethasone tablets
DRUG
2 trials
Sponsors
National Cancer Institute (NCI)
, pharmaand GmbH
Conditions
Carcinoma, Non-Small-Cell Lung
Multiple Myeloma
Phase 1
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Terminated
NCT00923273
National Cancer Institute (NCI)
Carcinoma, Non-Small-Cell Lung
Start: 2008-02-29
End: 2013-03-10
Updated: 2019-11-26
Phase 2
Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma
Completed
NCT02654990
pharmaand GmbH
Multiple Myeloma
Start: 2016-04-27
End: 2022-08-15
Updated: 2024-07-12
Related Papers
Subgroup Analysis: Efficacy and Safety of Panobinostat in Combination with SC Bortezomib and Oral Dexamethasone in Multiple Myeloma Patients with Lenalidomide-Refractory Disease
Blood
2021-11-05
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study.
2020-12-07
42 citations
Efficacy and Safety of the Panobinostat-Bortezomib-Dexamethasone Combination in Relapsed or Relapsed/Refractory Multiple Myeloma: Results from the Randomized Panorama 3 Study
Blood
2020-11-05
4 citations
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer
Translational Lung Cancer Research
2019-06-01
15 citations